Clinical trials

  • PACLITAXEL for Non-small cell lung cancer (resectable, early-stage II–IIIB)
  • MARIBAVIR for Cytomegalovirus (CMV) infection (post-transplant)
  • BARICITINIB for Type 1 diabetes
  • Atezolizumab for HER2-positive breast cancer | Advanced breast cancer
  • SUFENTANIL for Chronic postsurgical pain | Chronic postsurgical pain after non-major scheduled abdominal surgery
  • LU AG09222 for Migraine
  • RITUXIMAB for Systemic sclerosis-associated interstitial lung disease|Systemic sclerosis
  • Caspofungin for Pneumocystis jirovecii pneumonia
  • Vedolizumab for Ulcerative colitis | Crohn's disease
  • LEBRIKIZUMAB for Perennial allergic rhinitis
  • OSIMERTINIB for Non-small cell lung cancer (EGFR mutation-positive)
  • Irinotecan hydrochloride for Metastatic colorectal cancer (BRAF V600E-mutated) | Colorectal adenocarcinoma